IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $331,672 | +12.7% | 7,312 | +2.0% | 0.03% | +14.8% |
| Q2 2023 | $294,226 | -38.3% | 7,171 | -43.2% | 0.03% | -70.3% |
| Q4 2022 | $476,808 | +5.3% | 12,624 | +23.2% | 0.09% | -3.2% |
| Q3 2022 | $453,000 | 0.0% | 10,248 | -16.2% | 0.09% | -45.7% |
| Q2 2022 | $453,000 | +62.9% | 12,225 | +62.6% | 0.17% | +66.3% |
| Q1 2022 | $278,000 | -22.8% | 7,518 | -36.5% | 0.10% | +8.3% |
| Q4 2021 | $360,000 | +6.2% | 11,845 | +106.0% | 0.10% | +28.0% |
| Q2 2020 | $339,000 | 0.0% | 5,749 | -19.8% | 0.08% | -93.1% |
| Q1 2020 | $339,000 | – | 7,168 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |